Khawli LA - Search Results

1

Construction and preclinical characterization of Fc-mGITRL for the immunotherapy of cancer.

Hu P, Arias RS, Sadun RE, Nien YC, Zhang N, Sabzevari H, Lutsiak ME, Khawli LA, Epstein AL. Hu P, et al. Among authors: khawli la. Clin Cancer Res. 2008 Jan 15;14(2):579-88. doi: 10.1158/1078-0432.CCR-07-0940. Clin Cancer Res. 2008. PMID: 18223234

2

An improved method of direct labeling monoclonal antibodies with 99mTc.

Alauddin MM, Khawli LA, Epstein AL. Alauddin MM, et al. Among authors: khawli la. Int J Rad Appl Instrum B. 1992 May;19(4):445-54. doi: 10.1016/0883-2897(92)90159-v. Int J Rad Appl Instrum B. 1992. PMID: 1526809

3

Enhanced tumor uptake of macromolecules induced by a novel vasoactive interleukin 2 immunoconjugate.

LeBerthon B, Khawli LA, Alauddin M, Miller GK, Charak BS, Mazumder A, Epstein AL. LeBerthon B, et al. Among authors: khawli la. Cancer Res. 1991 May 15;51(10):2694-8. Cancer Res. 1991. PMID: 2021947

4

A human-mouse chimeric Lym-1 monoclonal antibody with specificity for human lymphomas expressed in a baculovirus system.

Hu P, Glasky MS, Yun A, Alauddin MM, Hornick JL, Khawli LA, Epstein AL. Hu P, et al. Among authors: khawli la. Hum Antibodies Hybridomas. 1995;6(2):57-67. Hum Antibodies Hybridomas. 1995. PMID: 7492752

5

Identification of a monoclonal antibody, TV-1, directed against the basement membrane of tumor vessels, and its use to enhance the delivery of macromolecules to tumors after conjugation with interleukin 2.

Epstein AL, Khawli LA, Hornick JL, Taylor CR. Epstein AL, et al. Among authors: khawli la. Cancer Res. 1995 Jun 15;55(12):2673-80. Cancer Res. 1995. PMID: 7780984

6

Effect of seven new vasoactive immunoconjugates on the enhancement of monoclonal antibody uptake in tumors.

Khawli LA, Miller GK, Epstein AL. Khawli LA, et al. Cancer. 1994 Feb 1;73(3 Suppl):824-31. doi: 10.1002/1097-0142(19940201)73:3+<824::aid-cncr2820731312>3.0.co;2-v. Cancer. 1994. PMID: 8306266

7

A chimeric Lym-1/interleukin 2 fusion protein for increasing tumor vascular permeability and enhancing antibody uptake.

Hu P, Hornick JL, Glasky MS, Yun A, Milkie MN, Khawli LA, Anderson PM, Epstein AL. Hu P, et al. Among authors: khawli la. Cancer Res. 1996 Nov 1;56(21):4998-5004. Cancer Res. 1996. PMID: 8895756

8

Chimeric CLL-1 antibody fusion proteins containing granulocyte-macrophage colony-stimulating factor or interleukin-2 with specificity for B-cell malignancies exhibit enhanced effector functions while retaining tumor targeting properties.

Hornick JL, Khawli LA, Hu P, Lynch M, Anderson PM, Epstein AL. Hornick JL, et al. Among authors: khawli la. Blood. 1997 Jun 15;89(12):4437-47. Blood. 1997. PMID: 9192768 Free article.

9

Exploration of novel strategies to enhance monoclonal antibodies targeting.

Khawli LA, Epstein AL. Khawli LA, et al. Q J Nucl Med. 1997 Mar;41(1):25-35. Q J Nucl Med. 1997. PMID: 9195850 Review.

10

Antitumor effects of nonconjugated murine Lym-2 and human-mouse chimeric CLL-1 monoclonal antibodies against various human lymphoma cell lines in vitro and in vivo.

Funakoshi S, Hirano A, Beckwith M, Asai O, Jorgensen G, Tian Z, Hornick JL, Hu P, Khawli LA, Epstein AL, Longo DL, Murphy WJ. Funakoshi S, et al. Among authors: khawli la. Blood. 1997 Oct 15;90(8):3160-6. Blood. 1997. PMID: 9376598 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

86 results

Search Page

Filters